Once yearly cell-based therapy for sustained and dose tunable delivery of monoclonal antibodies
Cody Fell, Anthony E. Davis, Shalini Pandey, Michael Tyler Guinn, Zeshi Wang, Jonathon DeBonis, Chancellor Smith, Nathan Brown, Danna Murungi, 김연주, Imaan Mohandessi, Patrick Bednarz, Amir Ardeshir, Erin Haupt, Samuel Cuevas, , Omid Veiseh A
This paper develops a cell-based therapy that enables sustained, dose-tunable delivery of monoclonal antibodies through a single administration, demonstrating long-term efficacy and safety in preclinical models.
Science Advances · Oct 2, 2026Peer-reviewedBioengineering